Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Redx Pharma
Redx Pharma
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part I
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Effective ways to optimise heat exchangers
Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Upcoming event
Lounges
23-25 April 2024 | Conference | Messe Karlsruhe, Germany
See all
Related Content
Ingredients
Redx signs licensing agreement with AstraZeneca for porcupine inhibitor
AstraZeneca will take RXC006 forward into clinical development, targeting fibrotic diseases including idiopathic pulmonary fibrosis
Finance
Redx Pharma appoints Sarah Gordon as non-executive Director
Gordon has been appointed due to deep experience of the biotechnology industry and capital markets
Research & Development
Redx Pharma announces new drug development candidate for fibrosis
First-in-human studies earmarked for 2020
Research & Development
Quay Pharma to supply promising cancer drug for trial
Quay Pharma has reached an agreement with Redx Pharma to manufacture Redx’s breakthrough cancer treatment drug
Research & Development
Redx Pharma set for new HQ at Alderley Park, Cheshire
Will bring together its three subsidiaries Redx Oncology, Redx Anti-Infectives and Redx Immunology onto one site
Research & Development
Redx Pharma launches £24m immunology R&D centre
Receives £4.2m of funding from the UK Government's Regional Growth Fund to be matched with proceeds from AIM listing
Research & Development
Redx Pharma and Pierre Fabre collaborate in skin cancer drug field
Will together develop a small molecule programme for an undisclosed cancer target
Subscribe now